10x Genomics, Inc. is trading at $30.85 (up 5.7%) as shares rebound following the approval of all proposals at the company's annual shareholder meeting.
- Shareholders ratified director elections and auditor appointments during the June 4, 2026, meeting, effectively removing a lingering governance overhang.
- The stock is also benefiting from a broader relief rally in U.S. growth and technology sectors following recent macro-driven volatility and sharp tech-led declines.